August 7, 2026 · Gynecologic oncology · DOI: 10.1016/j.ygyno.2026.08.003

Factors associated with non-completion of gynecological cancer clinical trials

Listen to this summary

The authors aimed to identify trial-level characteristics associated with the non-completion of gynecologic cancer clinical trials. Their analysis of 1,033 trials revealed that 30.3% did not complete, with factors such as intervention type, year of initiation, and U.S. region significantly influencing non-completion rates. The study highlights the need for improved trial design and feasibility planning to enhance the efficiency of gynecologic oncology research.

Paige Lange, Simran A Kanal, Yuva Vidwans, Miriam Donneyong, Caitlin E Meade, Janelle P Darby, Jennifer A Sinnott, Ashley S Felix

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play